This study aimed to elucidate the incidence and distribution of the cortical retention of Pittsburgh compound B (PIB) in patients with idiopathic normal pressure hydrocephalus (iNPH) and clarify the differences from those in patients with Alzheimer's disease (AD). Ten patients with iNPH without any clinical signs indicative of AD were enrolled in this study. Cerebral retention of PIB in positron emission tomography (PET) in iNPH patients was compared with those in seven age-matched AD patients. The CSF levels of β-amyloid 1-42 peptide (Aβ42), which inversely decrease with cerebral amyloid burden, were also measured. Three of the ten patients with iNPH showed increased cortical PIB retention. Although the mean cortical SUV ratios were similar, the distribution of PIB retention differed widely between the patients with iNPH and AD. PIB retention was limited to the high-convexity parasagittal areas in iNPH patients, whereas it spread over the frontal and parietotemporal areas in AD. The coronal images of PIB-PET were more informative than conventional transverse images in evaluating the distribution pattern of cortical PIB retention. Two iNPH patients with higher cortical PIB retention had the lowest levels of CSF Aβ42, indicating that PIB retention in iNPH would not reflect a simple delay in PIB clearance but its binding to existing Aβ amyloid in the brain. Our results indicate that iNPH is one of the diseases exhibiting cortical PIB retention. The characteristic distribution of PIB retention in iNPH could be useful in the differential diagnosis between iNPH and AD.
Introduction
Idiopathic normal pressure hydrocephalus (iNPH) causes gait disturbance, cognitive decline and urinary incontinence which can be ameliorated by shunt operation. One of the potential factors that may negatively influence shunt responsiveness is the presence of comorbidity, especially Alzheimer's disease (AD) that results in progressive dementia 1, 2 . It is hence essential to make an accurate diagnosis on whether each patient with iNPH has comorbid AD.
Recently, positron emission tomography (PET) using 11 C-labeled radiotracer Pittsburgh compound B (PIB) has been widely applied for the in vivo assessment of amyloid-β (Aβ) deposition in patients with AD, with successful results 3, 4 . It is thus conceivable that this PIB-PET study may be useful for the diagnosis of comorbid AD in iNPH patients. However, there remains a possibility that iNPH patients may also have PIB retention, since cortical Aβ deposition has been found in biopsied cortical tissues in 42-75 % of iNPH patients examined 2, 5, 6 . No previous study has investigated whether iNPH patients without comorbid AD may exhibit PIB retention. Thus, the aim of our study was to determine whether cortical PIB retention exists brain magnetic resonance imaging (MRI), and single photon emission computed tomography (SPECT) cerebral blood flow imaging. This study included only those iNPH patients confirmed to have neither AD-like brain atrophy in medial temporal lobes by MRI nor AD-like hypoperfusion in parietotemporal, posterior cingulate or precuneus cortices by SPECT imaging.
All the examined subjects provided written informed consent to participate in the study, which was approved by the University Ethics Committee (Kyoto Prefectural University of Medicine, Kyoto, Japan).
Acquisition and Analysis of PIB-PET Data
Pittsburgh compound B (PIB: N-Methyl-[ 11 C]2-(4-methylaminophenyl)-6-hydroxybenzothiazole) was prepared at Nishijin Hospital (Kyoto). PIB radiosynthesis was performed using a simplified method reported by Wilson et al. 9 . PIB was injected intravenously (555 ± 185MBq, 15 ± 5mCi) as a slow bolus for 10-20 seconds. PET scanning was performed using a Siemens ECAT ACCEL scanner (Siemens Medical Systems, Erlangen, Germany) equipped with LSO crystals (3D mode, 16.2 cm field of view, 47 planes) with 35 dynamic frames acquired over 70 min. The ECAT ACCEL has a transaxial spatial resolution of 6.3 mm full width at half maximum (FWHM) measured at 1 cm off-axis, and of 6.8 mm measured at 10 cm off-axis. The axial resolution is 4.7 mm at the centre of the system. Attenuation correc-in patients with iNPH. We performed PIB-PET study in patients with "pure" iNPH without any clinical signs of AD. We found that small fraction of pure iNPH patients had cortical PIB retention, but with quite a different distribution pattern from that seen in AD.
Subjects and Methods

Subjects
Ten patients with iNPH (six men and four women, aged 79.2 ± 5.0 years, 24.5 ± 1.9 in Mini-Mental State Examination (MMSE) scores (mean ± standard deviation)) were enrolled in this study (Table 1) . Among the iNPH patients, none had obvious dementia with impairment of usual activities of daily living, but seven of them were diagnosed as having mild cognitive impairment (MCI) because of their cognitive concern reported by themselves or their caregivers and cognitive tests ( Table 1) . Cerebral retention of PIB in those iNPH patients was compared with those in seven age-matched AD patients (four men and three women, aged 70.4 ± 11.3 years). The iNPH patients consisted of those with probable (n = 8) or definite (n = 2) iNPH, diagnosed according to the Japanese guidelines for iNPH 7 . The AD patients were diagnosed as probable AD according to the standard clinical criteria 8 . Before diagnosis, all the iNPH subjects underwent clinical examinations including neurological and neuropsychological examinations, routine blood analyses, Table 1 ) and with (B, patient 9) cortical PIB retention and AD (C) showing different patterns of cortical PIB retention between the two diseases. The color bar on the right indicates the standardized uptake values.
frontal cortices (dorsal and ventral), lateral temporal cortices, medial temporal cortices (amygdala and hippocampus), lateral parietal cortices, occipital cortices, precuneus and cerebellum, while parasagittal areas included anterior cingulate gyri and precuneus, which were modifications of a previous method to concentrate ROIs in cortical areas 10 . PMOD software (version 3.2, PMOD Technologies Ltd., Zurich, Switzerland) was used to extract count data for specified ROI. A mean cortical PIB retention measurement was also computed across cortical ROIs without including the cerebellum. The PIB retention outcomes were evaluated tion was performed using transmission scans, obtained using three rotating germanium-68 rod sources. PET data were reconstructed using the ordered subsets expectation maximization (OSEM) algorithm, with six iterations and 16 subsets. The reconstructed images were displayed in coronal, transverse and sagittal planes for analysis. Regions of interest (ROI)s were manually generated for 18 regions on each PET image by one experienced neurologist and one experienced radiologist familiar with the neuroanatomy (MK and SM). The locations of the ROIs included bilateral anterior cingulate gyri, Figure 2 A) Cortical standardized uptake value (SUV) ratio calculated using cerebellar SUV as the reference in each patient of the iNPH (n = 10) and AD (n = 7) groups. p = 0.088; Mann-Whitney test. B) The PS/PT ratio in each patient with iNPH showing cortical PIB retention (n = 3), and that of AD (n = 7). p = 0.017; Mann-Whitney test. C) CSF levels of Aβ42 in each iNPH patient without (C(-), n = 7) and with (C(+), n = 2) cortical PIB retention. Horizontal bars in A-C indicate the mean values.
The mean cortical SUVR had no significant correlation either with MMSE score or measures of timed up-and-go (TUG) tests (required time or steps) in iNPH patients (data not shown).
The levels of CSF Aβ42 were measured in nine patients with iNPH, including two cases with higher cortical PIB retention; those two patients showed the lowest levels of CSF Aβ42 among the nine iNPH patients ( Figure 2C) . This low CSF level indicates that there is an actual deposition of Aβ amyloid in the brain, and PIB retention in iNPH would not therefore reflect a delay in the clearance of PIB from the brain tissue but its real binding to cerebral Aβ amyloid.
Discussion
We have demonstrated here that three out of ten (30%) patients with iNPH without any clinical signs of AD had obvious cortical retention in PIB-PET, indicating that iNPH is one of the PIB-positive diseases. We also revealed that the pattern of cortical PIB retention seen in iNPH patients was characteristic of iNPH, limited to the high-convexity parasagittal areas showing a high PS/PT ratio ( Figure 2B ). This pattern was apparently different from that in AD with high retention in parietotemporal cortices showing a low PS/PT ratio. All three iNPH patients with positive cortical PIB retention were diagnosed as having MCI in cognitive tests. It will be very interesting to see whether or not and how fast their cognitive functions will deteriorate in the course of their iNPH, compared with the usual course of AD. We are therefore planning a longitudinal follow-up on these patients.
Our data also suggest that differentiation between cognitive decline due to iNPH alone and due to comorbid AD pathology may be possible, not by the CSF Aβ42 levels, but by the distribution pattern of PIB-positive cortical amyloid. This was most effectively judged based on coronal images rather than conventional transverse images. These results indicate the possible role of PIB-PET in the diagnosis of the etiology of dementia in iNPH, which could be valuable in considering a shunt indication.
Aβ-amyloid deposition depends on the local balance between production and clearance. It has been reported that local Aβ production increases in specific brain regions correlating with synaptic activity or aerobic glycolysis 11, 12 . In AD patients, some of those regions belong to based on the standardized uptake value (SUV) measures. SUVs were determined over 50-70 minutes post injection intervals and normalized to injected dose and body mass. SUV ratio (SUVR) was generated using the cerebellum as reference.
Coronal sections of PIB-PET images across precuneus areas were analyzed using an arbitrary index, SUVR measured in parasagittal (PS) and parietotemporal (PT) areas (the PS/ PT ratio). The PS/PT ratio was calculated using the formula: PS/PT ratio = (right PS/PT + left PS/PT)/2.
Measurement of Aβ42 in Cerebrospinal Fluid
To evaluate the extent of amyloid burden in each patient's brain, cerebrospinal fluid (CSF) levels of β-amyloid 1-42 peptide (Aβ42) which are known to decrease inversely with the extent of cerebral amyloid deposition were determined by sandwich ELISA according to the manufacturer's instructions (Human/Rat β Amyloid (42) ELISA Kit, Wako, Osaka, Japan) in nine of the ten patients with iNPH who agreed to undergo the test.
Statistical Analysis
We compared iNPH and AD groups using the Mann-Whitney U test. The level of statistical significance was set at p < 0.05. All statistical analyses were performed using SPSS (Dr SPSS II version, SPSS Japan Inc., Tokyo, Japan).
Results
Three of the ten patients with iNPH, all of whom were diagnosed as MCI in cognitive tests, showed increased cortical PIB retention, especially in the bilateral high-convexity parasagittal areas (Table 1, Figure 1B) . The mean cortical SUVRs, calculated using cerebellar SUV as the reference, did not significantly differ between iNPH and AD patients (Figure 2A ). However, the distribution of cortical PIB retention was clearly different between the two groups. PIB retention was limited to the high-convexity parasagittal areas in iNPH patients, while it spread over the frontal and parietotemporal areas in AD ( Figure 1B) . This was confirmed by the mean PS/PT ratio that was significantly higher in iNPH patients with cortical PIB retention than in AD patients (p=0.017) ( Figure 2B ). sider PIB retention in iNPH would reflect the actual accumulation of Aβ amyloid because the iNPH patients with high cortical PIB retention showed lower CSF levels of Aβ42, indicating the presence of actual amyloid deposition in the cerebral cortex.
Conclusion
iNPH is one of the diseases that may present cortical PIB retention. However, the distribution of PIB retention differs widely from that in typical AD patients and is limited to the highconvexity parasagittal areas, thus distinguishing the two conditions. a group of brain areas called the default mode network 13 . Thus, the deposition of Aβ amyloid in AD brain is caused by the combination of both increased local Aβ production in parietotemporal cortices and decreased Aβ clearance due to aging.
On the other hand, in the iNPH patients' brains, cortical Aβ deposition is conceivably attributed mainly to the decrease in local Aβ clearance. It is well-known that CSF turnover is much slower in iNPH 14 . Since the upper half of the brain is passively lifted cranially in these patients, the high-convexity parasagittal regions will be compressed and there will be less interstitial fluid 15 . This could lead to a decline in local clearance of Aβ, which would ultimately lead to local Aβ-amyloid depositions.
There is a possibility that the cortical PIB retention in iNPH might be attributable to other causes. One possibility is that it does not reflect a real accumulation of Aβ amyloid but merely picks up the delay in the clearance of administered PIB from the brain due to the slower turnover of CSF 14 . However, we con-
